219 related articles for article (PubMed ID: 16474432)
1. Therapy of cancer by cytokines mediated by gene therapy approach.
Qian C; Liu XY; Prieto J
Cell Res; 2006 Feb; 16(2):182-8. PubMed ID: 16474432
[TBL] [Abstract][Full Text] [Related]
2. [Construction of a RU486 inducible recombinant adenoviral vector carrying murine interleukin-12 gene and experimental treatment of colonic carcinoma].
Chen J; Liu XS; Wang F; Xue XC; Fang GE; Su CQ; Qian QJ
Zhonghua Yi Xue Za Zhi; 2009 May; 89(20):1372-6. PubMed ID: 19671324
[TBL] [Abstract][Full Text] [Related]
3. Increased efficacy and safety in the treatment of experimental liver cancer with a novel adenovirus-alphavirus hybrid vector.
Guan M; Rodriguez-Madoz JR; Alzuguren P; Gomar C; Kramer MG; Kochanek S; Prieto J; Smerdou C; Qian C
Cancer Res; 2006 Feb; 66(3):1620-9. PubMed ID: 16452221
[TBL] [Abstract][Full Text] [Related]
4. Gene-viral vectors: a promising way to target tumor cells and express anticancer genes simultaneously.
Qian Q; Sham J; Che X; Xu J; Xue H; Cui Z; Zhu B; Wu M
Chin Med J (Engl); 2002 Aug; 115(8):1213-7. PubMed ID: 12215295
[TBL] [Abstract][Full Text] [Related]
5. Prolonged and inducible transgene expression in the liver using gutless adenovirus: a potential therapy for liver cancer.
Wang L; Hernández-Alcoceba R; Shankar V; Zabala M; Kochanek S; Sangro B; Kramer MG; Prieto J; Qian C
Gastroenterology; 2004 Jan; 126(1):278-89. PubMed ID: 14699506
[TBL] [Abstract][Full Text] [Related]
6. Eradication of murine bladder carcinoma by intratumor injection of a bicistronic adenoviral vector carrying cDNAs for the IL-12 heterodimer and its inhibition by the IL-12 p40 subunit homodimer.
Chen L; Chen D; Block E; O'Donnell M; Kufe DW; Clinton SK
J Immunol; 1997 Jul; 159(1):351-9. PubMed ID: 9200473
[TBL] [Abstract][Full Text] [Related]
7. Treatment of cancer with a novel dual-targeted conditionally replicative adenovirus armed with mda-7/IL-24 gene.
Luo J; Xia Q; Zhang R; Lv C; Zhang W; Wang Y; Cui Q; Liu L; Cai R; Qian C
Clin Cancer Res; 2008 Apr; 14(8):2450-7. PubMed ID: 18413837
[TBL] [Abstract][Full Text] [Related]
8. Targeting gene-virotherapy of cancer.
Liu XY; Gu JF
Cell Res; 2006 Jan; 16(1):25-30. PubMed ID: 16467873
[TBL] [Abstract][Full Text] [Related]
9. A potent replicative delta-24 adenoviral vector driven by the promoter of human papillomavirus 16 that is highly selective for associated neoplasms.
Delgado-Enciso I; Cervantes-García D; Martínez-Dávila IA; Ortiz-López R; Alemany-Bonastre R; Silva-Platas CI; Lugo-Trampe A; Barrera-Saldaña HA; Galván-Salazar HR; Coronel-Tene CG; Sánchez-Santillán CF; Rojas-Martínez A
J Gene Med; 2007 Oct; 9(10):852-61. PubMed ID: 17729237
[TBL] [Abstract][Full Text] [Related]
10. A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo.
Li B; Liu X; Fan J; Qi R; Bo L; Gu J; Qian Q; Qian C; Liu X
J Gene Med; 2006 Oct; 8(10):1232-42. PubMed ID: 16900558
[TBL] [Abstract][Full Text] [Related]
11. Systemic production of IL-12 by naked DNA mediated gene transfer: toxicity and attenuation of transgene expression in vivo.
Lui VW; Falo LD; Huang L
J Gene Med; 2001; 3(4):384-93. PubMed ID: 11529668
[TBL] [Abstract][Full Text] [Related]
12. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
13. Enhanced antitumor effect of combined replicative adenovirus and nonreplicative adenovirus expressing interleukin-12 in an immunocompetent mouse model.
Nagayama Y; Nakao K; Mizuguchi H; Hayakawa T; Niwa M
Gene Ther; 2003 Aug; 10(16):1400-3. PubMed ID: 12883537
[TBL] [Abstract][Full Text] [Related]
14. A simplified system for generating oncolytic adenovirus vector carrying one or two transgenes.
Hu ZB; Wu CT; Wang H; Zhang QW; Wang L; Wang RL; Lu ZZ; Wang LS
Cancer Gene Ther; 2008 Mar; 15(3):173-82. PubMed ID: 18157145
[TBL] [Abstract][Full Text] [Related]
15. Targeting gene-virotherapy of cancer and its prosperity.
Liu XY
Cell Res; 2006 Nov; 16(11):879-86. PubMed ID: 17102812
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic immune response induced by intratumoral expression of the fusogenic membrane protein of vesicular stomatitis virus and cytokines encoded by adenoviral vectors.
Hoffmann D; Bayer W; Wildner O
Int J Mol Med; 2007 Nov; 20(5):673-81. PubMed ID: 17912460
[TBL] [Abstract][Full Text] [Related]
17. Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect.
Choi KJ; Kim JH; Lee YS; Kim J; Suh BS; Kim H; Cho S; Sohn JH; Kim GE; Yun CO
Gene Ther; 2006 Jul; 13(13):1010-20. PubMed ID: 16525479
[TBL] [Abstract][Full Text] [Related]
18. Advantages and limitations of particle-mediated transfection (gene gun) in cancer immuno-gene therapy using IL-10, IL-12 or B7-1 in murine tumor models.
Kitagawa T; Iwazawa T; Robbins PD; Lotze MT; Tahara H
J Gene Med; 2003 Nov; 5(11):958-65. PubMed ID: 14601133
[TBL] [Abstract][Full Text] [Related]
19. Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model.
Lee YS; Kim JH; Choi KJ; Choi IK; Kim H; Cho S; Cho BC; Yun CO
Clin Cancer Res; 2006 Oct; 12(19):5859-68. PubMed ID: 17020994
[TBL] [Abstract][Full Text] [Related]
20. Helper-dependent adenovirus vectors devoid of all viral genes cause less myocardial inflammation compared with first-generation adenovirus vectors.
Fleury S; Driscoll R; Simeoni E; Dudler J; von Segesser LK; Kappenberger L; Vassalli G
Basic Res Cardiol; 2004 Jul; 99(4):247-56. PubMed ID: 15221342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]